Related Experiment Videos
Interventions for idiopathic intracranial hypertension
1Department of Clinical Neurosciences, Western General Hospital, Crewe Road, Edinburgh, Scotland, UK, EH4 2XU. cl@skull.dcn.ed.ac.uk
The Cochrane Database of Systematic Reviews
|July 26, 2002
Summary
No randomized controlled trials were found for idiopathic intracranial hypertension (IIH) treatments. More high-quality research is needed to determine effective management strategies for this condition.
Area of Science:
- Neurology
- Ophthalmology
- Clinical Trials
Background:
- Idiopathic intracranial hypertension (IIH) affects 1-3 per 100,000 people annually, primarily young, obese women.
- IIH poses a significant risk to vision and causes severe headaches.
- Current treatments range from diuretics to surgical interventions like optic nerve sheath fenestration.
Purpose of the Study:
- To review evidence from controlled trials on idiopathic intracranial hypertension (IIH) treatments.
- To develop an evidence-based treatment strategy for IIH.
Main Methods:
- Searched Cochrane Controlled Trials Register, MEDLINE, and EMBASE up to 2002.
- Included only randomized controlled trials comparing IIH treatments to placebo or other treatments.
- Two reviewers independently assessed trial eligibility; no quality assessment or meta-analysis was performed due to lack of trials.
Main Results:
- No randomized controlled trials meeting the inclusion criteria were identified.
- The review could not assess the quality or effectiveness of any IIH treatments.
Conclusions:
- Insufficient evidence exists to create an evidence-based management strategy for IIH.
- The efficacy and potential harm of current IIH treatments are largely unknown.
- There is a critical need for well-designed, randomized controlled trials to guide IIH treatment.